Source: Gov.uk
Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping.
New data have confirmed that the risk of breast cancer is increased during use of all types of HRT, except vaginal estrogens, and have also shown that an excess risk of breast cancer persists for longer after stopping HRT than previously thought. This Drug Safety Update from the MHRA recommends that prescribers of HRT should discuss the updated total risk with women using HRT at their next routine appointment.
